VALO HEALTH

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark VALO HEALTH was filed as Word mark on 12/03/2020 at the World Intellectual Property Organization.

Trademark Details Last update: March 29, 2023

Trademark form Word mark
File reference 1570709
Countries Australia Canada Switzerland China European Community United Kingdom Israel Japan Singapore
Base trademark US No. 88945793, June 3, 2020
Application date December 3, 2020
Expiration date December 3, 2030

Trademark owner

399 Boylston Street, Suite 505
Boston MA 02116
US

Trademark representatives

151 W 42nd St., 17th Floor New York NY 10036 US

goods and services

01 Chemical and biological agents for scientific and research use
05 Pharmaceutical preparations for treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders and therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders
09 Downloadable computer software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biology, biochemistry
36 Venture capital funding services to emerging and start-up companies; providing venture capital, development capital, private equity and investment funding; venture capital advisory services; hedge fund investment services
42 Pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, and genomics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for use in clinical trials; providing on-line non-downloadable computer software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing on-line non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, biology, biochemistry

Trademark history

Date Document number Area Entry
March 20, 2023 2023/13 Gaz AU Rejection
May 6, 2022 2022/19 Gaz CA Rejection
April 28, 2022 2022/18 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 26, 2022 2022/23 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 2, 2022 2022/13 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 23, 2021 2021/52 Gaz CH Rejection
November 25, 2021 2021/47 Gaz JP Rejection
October 10, 2021 2021/42 Gaz IL Rejection
September 16, 2021 2021/37 Gaz GB Rejection
June 2, 2021 2021/22 Gaz EM Rejection
May 26, 2021 2021/22 Gaz SG Rejection
May 19, 2021 2021/26 Gaz CN Rejection
April 29, 2021 2021/19 Gaz IL Rejection
February 12, 2021 2021/7 Gaz AU Rejection
December 3, 2020 2020/53 Gaz US Registration

ID: 141570709